The US National Cancer Institute has launched a project to figure out how to block the Ras protein, ScienceInsider reports. Mutated Ras is present in about a third of all cancers and Ras has long been thought to be undruggable as it does not have an obvious binding site. "Researchers have begun to find some weak spots in RAS, however, and NCI now thinks it is time for a coordinated attack on this protein," ScienceInsider notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.